257 related articles for article (PubMed ID: 24141029)
1. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.
Suriguga ; Li XF; Li Y; Yu CH; Li YR; Yi ZC
Toxicol Appl Pharmacol; 2013 Dec; 273(3):635-43. PubMed ID: 24141029
[TBL] [Abstract][Full Text] [Related]
2. O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase.
Zhu BT; Patel UK; Cai MX; Conney AH
Drug Metab Dispos; 2000 Sep; 28(9):1024-30. PubMed ID: 10950844
[TBL] [Abstract][Full Text] [Related]
3. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
[TBL] [Abstract][Full Text] [Related]
4. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
5. Role of G proteins and ERK activation in hemin-induced erythroid differentiation of K562 cells.
Kucukkaya B; Arslan DO; Kan B
Life Sci; 2006 Feb; 78(11):1217-24. PubMed ID: 16216279
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols.
Lee WJ; Zhu BT
Carcinogenesis; 2006 Feb; 27(2):269-77. PubMed ID: 16081510
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation.
Goodman JE; Jensen LT; He P; Yager JD
Pharmacogenetics; 2002 Oct; 12(7):517-28. PubMed ID: 12360102
[TBL] [Abstract][Full Text] [Related]
8. Increased glutathione S-transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cells.
Schnekenburger M; Morceau F; Duvoix A; Delhalle S; Trentesaux C; Dicato M; Diederich M
Biochem Pharmacol; 2004 Sep; 68(6):1269-77. PubMed ID: 15313425
[TBL] [Abstract][Full Text] [Related]
9. Expression of functional membrane-bound and soluble catechol-O-methyltransferase in Escherichia coli and a mammalian cell line.
Malherbe P; Bertocci B; Caspers P; Zürcher G; Da Prada M
J Neurochem; 1992 May; 58(5):1782-9. PubMed ID: 1560233
[TBL] [Abstract][Full Text] [Related]
10. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
11. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols.
Ovaska M; Yliniemelä A
J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of tellimagrandin I on chemically induced differentiation of human leukemia K562 cells.
Yi Z; Wang Z; Li H; Liu M
Toxicol Lett; 2004 Mar; 147(2):109-19. PubMed ID: 14757314
[TBL] [Abstract][Full Text] [Related]
13. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF
Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542
[TBL] [Abstract][Full Text] [Related]
15. Determination of catechol-O-methyltransferase activity in erythrocytes by high performance liquid chromatography with electrochemical detection.
Schultz E; Nissinen E; Kaakkola S
Biomed Chromatogr; 1989 Mar; 3(2):64-7. PubMed ID: 2736320
[TBL] [Abstract][Full Text] [Related]
16. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL
Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093
[TBL] [Abstract][Full Text] [Related]
17. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
18. Rapid conversion of tea catechins to monomethylated products by rat liver cytosolic catechol-O-methyltransferase.
Zhu BT; Patel UK; Cai MX; Lee AJ; Conney AH
Xenobiotica; 2001 Dec; 31(12):879-90. PubMed ID: 11780762
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic determination, with ultraviolet detection, of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine in rat tissues and simultaneously of normetanephrine and metanephrine for phenylethanolamine-N-methyltransferase or catechol-O-methyltransferase activities.
Guattari B
J Chromatogr; 1991 Jun; 567(1):254-60. PubMed ID: 1918253
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis.
Zhu BT
Curr Drug Metab; 2002 Jun; 3(3):321-49. PubMed ID: 12083324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
